Haemonetics Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.89 | $0.89 | $0.89 |
| Q2 2024 | 1 | $1.01 | $1.01 | $1.01 |
| Q3 2024 | 2 | $1.07 | $1.08 | $1.07 |
| Q4 2024 | 7 | $1.16 | $1.19 | $1.17 |
| Q1 2025 | 7 | $1.24 | $1.31 | $1.28 |
| Q2 2025 | 5 | $1.17 | $1.22 | $1.19 |
| Q3 2025 | 4 | $1.26 | $1.32 | $1.28 |
| Q4 2025 | 3 | $1.34 | $1.40 | $1.36 |
| Q1 2026 | 2 | $1.44 | $1.50 | $1.47 |
| Q2 2026 | 2 | $1.34 | $1.39 | $1.36 |
| Q3 2026 | 2 | $1.44 | $1.50 | $1.47 |
| Q4 2026 | 2 | $1.58 | $1.65 | $1.61 |
| Q1 2027 | 2 | $1.73 | $1.80 | $1.76 |
Haemonetics Corporation Earnings Date And Information
Haemonetics Corporation last posted its earnings results on Thursday, November 7th, 2024. The company reported $1.12 earnings per share for the quarter, topping analysts' consensus estimates of $1.09 by $0.03. The company had revenue of 345.51 M for the quarter and had revenue of 1.31 B for the year. Haemonetics Corporation has generated $2 earnings per share over the last year ($2.29 diluted earnings per share) and currently has a price-to-earnings ratio of 35.12. Haemonetics Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based on prior year's report dates.
Haemonetics Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q2 2025 | $1.09 | $0.66 | -0.43 | $342.57 M | $345.51 M |
| 08/08/2024 | Q1 2025 | $1.03 | $0.75 | -0.28 | $336.17 M | |
| 05/20/2024 | Q4 2024 | $0.40 | $343.29 M | |||
| 02/08/2024 | Q3 2024 | $0.97 | $0.62 | -0.35 | $336.25 M | |
| 11/02/2023 | Q2 2024 | $0.94 | $0.49 | -0.45 | $318.18 M | |
| 08/08/2023 | Q1 2024 | $0.73 | $0.81 | 0.08 | $311.33 M | |
| 05/22/2023 | Q4 2023 | $0.58 | $304.42 M | |||
| 02/07/2023 | Q3 2023 | $0.79 | $0.65 | -0.14 | $305.30 M | |
| 11/08/2022 | Q2 2023 | $0.65 | $297.49 M | |||
| 08/10/2022 | Q1 2023 | $0.53 | $0.39 | -0.14 | $261.46 M | |
| 05/25/2022 | Q4 2022 | $0.19 | $265.00 M | |||
| 02/08/2022 | Q3 2022 | $0.75 | $0.45 | -0.3 | $259.77 M | |
| 11/09/2021 | Q2 2022 | $0.63 | $0.29 | -0.34 | $239.90 M | |
| 08/11/2021 | Q1 2022 | $0.47 | -$0.09 | -0.56 | $228.53 M | |
| 05/26/2021 | Q4 2021 | -$0.22 | $225.03 M | |||
| 02/02/2021 | Q3 2021 | $0.65 | $0.63 | -0.02 | $240.37 M | |
| 11/04/2020 | Q2 2021 | $0.50 | $0.95 | 0.45 | $209.49 M | |
| 08/04/2020 | Q1 2021 | $0.41 | $0.21 | -0.2 | $195.58 M | |
| 05/20/2020 | Q4 2020 | $0.34 | $238.49 M | |||
| 02/04/2020 | Q3 2020 | $0.76 | $0.59 | -0.17 | $258.97 M |
Haemonetics Corporation Earnings: Frequently Asked Questions
-
When is Haemonetics Corporation's earnings date?
Haemonetics Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates.
-
Did Haemonetics Corporation beat their earnings estimates last quarter?
In the previous quarter, Haemonetics Corporation (:HAE) reported $1.12 earnings per share (EPS) to beat the analysts' consensus estimate of $1.09 by $0.03.
-
How can I listen to Haemonetics Corporation's earnings conference call?
The conference call for Haemonetics Corporation's latest earnings report can be listened to online.
-
How can I read Haemonetics Corporation's conference call transcript?
The conference call transcript for Haemonetics Corporation's latest earnings report can be read online.
-
How much revenue does Haemonetics Corporation generate each year?
Haemonetics Corporation (:HAE) has a recorded annual revenue of $1.31 B.
-
How much profit does Haemonetics Corporation generate each year?
Haemonetics Corporation (:HAE) has a recorded net income of $1.31 B. Haemonetics Corporation has generated $2.32 earnings per share over the last four quarters.
-
What is Haemonetics Corporation's price-to-earnings ratio?
Haemonetics Corporation (:HAE) has a price-to-earnings ratio of 35.12 and price/earnings-to-growth ratio is 4.67.
